InflaRx (IFRX) Shares Outstanding (Weighted Average) (2016 - 2026)

InflaRx has disclosed Shares Outstanding (Weighted Average) across 11 years of filings, most recently posting $415.6 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $415.6 million, up 13.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $415.6 million (up 13.22% YoY), and the FY2025 annual result was $413.2 million, up 5329.25% from the prior year.
• Shares Outstanding (Weighted Average) came in at $415.6 million for Q1 2026 at InflaRx, up from $413.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $415.6 million in Q1 2026 to a low of $330.79 in Q2 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $314.6 million (2022), against an average of $241.8 million.
• Across the five-year window, Shares Outstanding (Weighted Average) sank 100.0% in 2022 and jumped 91700470.64% in 2025, its largest moves.
• InflaRx's Shares Outstanding (Weighted Average) stood at $45.6 million in 2022, then soared by 38.91% to $63.4 million in 2023, then plunged by 87.99% to $7.6 million in 2024, then surged by 5329.25% to $413.2 million in 2025, then advanced by 0.58% to $415.6 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $415.6 million (Q1 2026), $413.2 million (Q4 2025), and $407.9 million (Q3 2025), per Business Quant data.